Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 25 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Laparoscopic gastric bypass vs laparoscopic adjustable gastric banding

Laparoscopic gastric bypass provides a higher excess weight loss at 18 months, compared with laparoscopic adjustable gastric banding, find doctors in the October issue of the Journal of the American College of Surgeons.

News image

fiogf49gjkf04

Obesity is an increasing concern.

The most common surgical procedures for obesity are the gastric bypass and the adjustable gastric banding. However, the indications and results of these techniques are unclear.

In the United States gastric bypass is regarded as the procedure which offers the best weight-loss outcome, but European surgeons prefer laparoscopic adjustable gastric banding.

Patients in the laparoscopic gastric bypass group were significantly heavier.
Journal of the American College of Surgeons

In this study, doctors from Switzerland and United States compared 2 groups of patients.

The first group included 805 obese patients from Switzerland who had a laparoscopic Swedish adjustable gastric banding (LAGB) performed between 1997 and 2001. The second group included 456 patients from the United States who had a laparoscopic gastric bypass (LGB) performed between 1998 and 2001.

The research team found that the patients in the LGB group were significantly heavier than those in the LAGB group.

However, they determined that postoperative stay after LGB was significantly less than after LAGB. This may be related to health system differences between the 2 countries.

The team identified 9 major intraoperative complications in the LGB group and 10 in the LAGB group.

They also found that 9 patients in the LGB group and 24 in the LAGB group required a conversion to another procedure. The primary cause of conversion was related to the obesity. In the first 30 days following surgery the team found there were no deaths in the LAGB group and 2 in the LGB group. However, there were 37 late major complications in the LGB group and 74 in the LAGB group.

After adjusting for preoperative weight, the team found that the mean excess weight loss (EWL) at 3 months was 36% after LGB versus 15% after LAGB. At 6 months EWL was 52% in the LGB group and 23% in the LAGB group, at 12 months 67% and 33%, and at 18 months 75% and 40%.

Dr Laurent Biertho's team concluded, "LGB provides a higher EWL at 18 months, compared with LAGB…this holds for all ranges of preoperative BMI".

"Both procedures can produce an EWL above 50%, but this criterion is met faster after LGB".

"The best indication for the two procedures is still unclear and probably depends on the patient's preoperative BMI, eating habits, and associated morbidities".

J Am Coll Surg 2003; 197(4): 536-45
03 October 2003

Go to top of page Email this page Email this page to a colleague

 23 February 2018 
Patients on antithrombotic agents undergoing emergency and elective endoscopy
 23 February 2018 
Heavy metals on a gluten-free diet
 23 February 2018 
MRI and NAFLD
 22 February 2018 
Outcomes with Crohn’s after infliximab withdrawal
 22 February 2018 
Elderly onset of IBD

 22 February 2018 
Autophagy enhancers
 21 February 2018 
Management of hemorrhoids in the USA
 21 February 2018 
Adalimumab and infliximab in biologic-naïve Crohn's
 21 February 2018 
Cystic fibrosis and colorectal cancer
 20 February 2018 
Complications and surveillance colonoscopies
 20 February 2018 
Treatment algorithm for polyp cancers
 20 February 2018 
Predictors of postoperative infection in Crohn's
 19 February 2018 
Screening colonoscopy in the right and left colon
 19 February 2018 
NAFLD prevalence in the USA
 19 February 2018 
Fructans in children with IBS

 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV
 29 January 2018 
Food allergen injections in eosinophilic esophagitis
 29 January 2018 
Reliability of the IBD index
 26 January 2018 
Tofacitinib vs biological therapies for ulcerative colitis

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us